Pathophysiology of X-linked adrenoleukodystrophy

Biochimie

Volumn 98, Issue 1, 2014, Pages 135-142

  Berger, J ^a   Forss Petter, S ^a   Eichler, F S ^b  

^a Medical University of Vienna   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ABC transporter; Axonopathy; Demyelination; Inflammation; Leukodystrophy; Peroxisome

Indexed keywords

ABC TRANSPORTER;

ADRENAL GLAND; ADRENOLEUKODYSTROPHY; BIOCHEMISTRY; CHILDHOOD ADRENOLEUKODYSTROPHY; ENCEPHALITIS; GENETIC CORRELATION; HETEROZYGOTE; HUMAN; LIPIDOMICS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; TESTIS;

ABC TRANSPORTER; AXONOPATHY; DEMYELINATION; INFLAMMATION; LEUKODYSTROPHY; PEROXISOME;

ADRENAL GLANDS; ADRENOLEUKODYSTROPHY; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; FEMALE; HAIR; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; TESTIS;

EID: 84895152385     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.11.023     Document Type: Short Survey

References (94)

1. L. Bezman, and H.W. Moser Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes Am. J. Med. Genet. 76 1998 415 419
2. S. Kemp, J. Berger, and P. Aubourg X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects Biochim. Biophys. Acta 1822 2012 1465 1474
3. H.W. Moser, K.D. Smith, P.A. Watkins, J. Powers, and A.B. Moser X-linked Adrenoleukodystrophy R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The Metabolic & Molecular Bases of Inherited Disease eighth ed. 2001 McGraw-Hill Book Co. New York 3257 3301
4. C. Peters, L.R. Charnas, Y. Tan, R.S. Ziegler, E.G. Shapiro, T. DeFor, S.S. Grewal, P.J. Orchard, S.L. Abel, A.I. Goldman, N.K. Ramsay, K.E. Dusenbery, D.J. Loes, L.A. Lockman, S. Kato, P.R. Aubourg, H.W. Moser, and W. Krivit Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999 Blood 104 2004 881 888
5. N. Cartier, S. Hacein-Bey-Abina, C.C. Bartholomae, G. Veres, M. Schmidt, I. Kutschera, M. Vidaud, U. Abel, L. Dal-Cortivo, L. Caccavelli, N. Mahlaoui, V. Kiermer, D. Mittelstaedt, C. Bellesme, N. Lahlou, F. Lefrere, S. Blanche, M. Audit, E. Payen, P. Leboulch, B. l'Homme, P. Bougneres, C. Von Kalle, A. Fischer, M. Cavazzana-Calvo, and P. Aubourg Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 326 2009 818 823
6. N. Cartier, and P. Aubourg Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy Brain Pathol. 20 2010 857 862
7. E. Hershkovitz, G. Narkis, Z. Shorer, A.B. Moser, P.A. Watkins, H.W. Moser, and E. Manor Cerebral X-linked adrenoleukodystrophy in a girl with Xq27-Ter deletion Ann. Neurol. 52 2002 234 237
8. H.W. Moser, A. Mahmood, and G.V. Raymond X-linked adrenoleukodystrophy Nat. Clin. Pract. Neurol. 3 2007 140 151
9. E.M. Maier, S. Kammerer, A.C. Muntau, M. Wichers, A. Braun, and A.A. Roscher Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation Ann. Neurol. 52 2002 683 688
10. R. Thibert, K. Hyland, J. Chiles, S. Steinberg, and F. Eichler Levodopa response reveals sepiapterin reductase deficiency in a female heterozygote with adrenoleukodystrophy JIMD Rep. 3 2012 79 82
11. J. Mosser, A.M. Douar, C.O. Sarde, P. Kioschis, R. Feil, H. Moser, A.M. Poustka, J.L. Mandel, and P. Aubourg Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters Nature 361 1993 726 730
12. S. Kemp, A. Pujol, H.R. Waterham, B.M. van Geel, C.D. Boehm, G.V. Raymond, G.R. Cutting, R.J. Wanders, and H.W. Moser ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations Hum. Mutat. 18 2001 499 515
13. C.W. van Roermund, W.F. Visser, L. Ijlst, H.R. Waterham, and R.J. Wanders Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation Biochim. Biophys. Acta 1811 2011 148 152
14. C.W. van Roermund, W.F. Visser, L. Ijlst, A. van Cruchten, M. Boek, W. Kulik, H.R. Waterham, and R.J. Wanders The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters FASEB J. 22 2008 4201 4208
15. C. Wiesinger, M. Kunze, G. Regelsberger, S. Forss-Petter, and J. Berger Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction J. Biol. Chem. 288 2013 19269 19279
16. K. Kamijo, S. Taketani, S. Yokota, T. Osumi, and T. Hashimoto The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily J. Biol. Chem. 265 1990 4534 4540
17. G. Lombard-Platet, S. Savary, C.O. Sarde, J.L. Mandel, and G. Chimini A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern Proc. Natl. Acad. Sci. U. S. A. 93 1996 1265 1269
18. A. Holzinger, S. Kammerer, J. Berger, and A.A. Roscher cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter Biochem. Biophys. Res. Commun. 239 1997 261 264
19. J. Berger, and J. Gartner X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects Biochim. Biophys. Acta 1763 2006 1721 1732
20. J. Berger, B. Molzer, I. Fae, and H. Bernheimer X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes Biochem. Biophys. Res. Commun. 205 1994 1638 1643
21. K.D. Smith, S. Kemp, L.T. Braiterman, J.F. Lu, H.M. Wei, M. Geraghty, G. Stetten, J.S. Bergin, J. Pevsner, and P.A. Watkins X-linked adrenoleukodystrophy: genes, mutations, and phenotypes Neurochem. Res. 24 1999 521 535
22. C.P. Guimaraes, M. Lemos, I. Menezes, T. Coelho, C. Sa-Miranda, and J.E. Azevedo Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP Hum. Genet. 109 2001 616 622
23. G.N. O'Neill, M. Aoki, and R.H. Brown Jr. ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN Neurology 57 2001 1956 1962
24. S. Kemp, F. Valianpour, S. Denis, R. Ofman, R.J. Sanders, P. Mooyer, P.G. Barth, and R.J. Wanders Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy Mol. Genet. Metab. 84 2005 144 151
25. C. Theda, A.B. Moser, J.M. Powers, and H.W. Moser Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination J. Eurol. Sci. 110 1992 195 204
26. P. Sharp, D. Johnson, and A. Poulos Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain J. Neurochem. 56 1991 30 37
27. M. Khan, K. Pahan, A.K. Singh, and I. Singh Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy J. Neurochem. 71 1998 78 87
28. H.H. Schaumburg, J.M. Powers, K. Suzuki, and C.S. Raine Adreno-leukodystrophy (sex-linked Schilder disease). Ultrastructural demonstration of specific cytoplasmic inclusions in the central nervous system Arch. Neurol. 31 1974 210 213
29. F.S. Eichler, J.Q. Ren, M. Cossoy, A.M. Rietsch, S. Nagpal, A.B. Moser, M.P. Frosch, and R.M. Ransohoff Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann. Neurol. 63 2008 729 742
30. W.C. Hubbard, A.B. Moser, A.C. Liu, R.O. Jones, S.J. Steinberg, F. Lorey, S.R. Panny, R.F. Vogt Jr., D. Macaya, C.T. Turgeon, S. Tortorelli, and G.V. Raymond Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method Mol. Genet. Metab. 97 2009 212 220
31. F. Fouquet, J.M. Zhou, E. Ralston, K. Murray, F. Troalen, E. Magal, O. Robain, M. Dubois-Dalcq, and P. Aubourg Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system Neurobiol. Dis. 3 1997 271 285
32. R. Hoftberger, M. Kunze, I. Weinhofer, F. Aboul-Enein, T. Voigtlander, I. Oezen, G. Amann, H. Bernheimer, H. Budka, and J. Berger Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy Neurobiol. Dis. 28 2007 165 174
33. R. Hoftberger, M. Kunze, T. Voigtlander, U. Unterberger, G. Regelsberger, J. Bauer, F. Aboul-Enein, F. Garzuly, S. Forss-Petter, H. Bernheimer, J. Berger, and H. Budka Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and beta-endorphin Endocrinology 151 2010 4801 4810
34. N. Troffer-Charlier, N. Doerflinger, E. Metzger, F. Fouquet, J.L. Mandel, and P. Aubourg Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines Eur. J. Cell Biol. 75 1998 254 264
35. J. Berger, S. Albet, M. Bentejac, A. Netik, A. Holzinger, A.A. Roscher, M. Bugaut, and S. Forss-Petter The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression Eur. J. Biochem. 265 1999 719 727
36. A. Netik, S. Forss-Petter, A. Holzinger, B. Molzer, G. Unterrainer, and J. Berger Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy Hum. Mol. Genet. 8 1999 907 913
37. S. Kemp, H.M. Wei, J.F. Lu, L.T. Braiterman, M.C. McGuinness, A.B. Moser, P.A. Watkins, and K.D. Smith Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy Nat. Med. 4 1998 1261 1268
38. S. Forss-Petter, H. Werner, J. Berger, H. Lassmann, B. Molzer, M.H. Schwab, H. Bernheimer, F. Zimmermann, and K.A. Nave Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice J. Neurosci. Res. 50 1997 829 843
39. J.F. Lu, A.M. Lawler, P.A. Watkins, J.M. Powers, A.B. Moser, H.W. Moser, and K.D. Smith A mouse model for X-linked adrenoleukodystrophy Proc. Natl. Acad. Sci. U. S. A. 94 1997 9366 9371
40. T. Kobayashi, N. Shinnoh, A. Kondo, and T. Yamada Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism Biochem. Biophys. Res. Commun. 232 1997 631 636
41. I. Oezen, W. Rossmanith, S. Forss-Petter, S. Kemp, T. Voigtlander, K. Moser-Thier, R.J. Wanders, R.E. Bittner, and J. Berger Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency Hum. Mol. Genet. 14 2005 1127 1137
42. A. Pujol, C. Hindelang, N. Callizot, U. Bartsch, M. Schachner, and J.L. Mandel Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy Hum. Mol. Genet. 11 2002 499 505
43. M. Dumser, J. Bauer, H. Lassmann, J. Berger, and S. Forss-Petter Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency Acta Neuropathol. 114 2007 573 586
44. J.F. Lu, E. Barron-Casella, R. Deering, A.K. Heinzer, A.B. Moser, K.L. deMesy, G.S. Bentley, C.M.M. Wand, Z. Pei, P.A. Watkins, A. Pujol, K.D. Smith, and J.M. Powers The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage Lab. Invest. 87 2007 261 272
45. A. Pujol, I. Ferrer, C. Camps, E. Metzger, C. Hindelang, N. Callizot, M. Ruiz, T. Pampols, M. Giros, and J.L. Mandel Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy Hum. Mol. Genet. 13 2004 2997 3006
46. E.M. Maier, P.U. Mayerhofer, M. Asheuer, W. Kohler, M. Rothe, A.C. Muntau, A.A. Roscher, A. Holzinger, P. Aubourg, and J. Berger X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype Biochem. Biophys. Res. Commun. 377 2008 176 180
47. T. Matsukawa, M. Asheuer, Y. Takahashi, J. Goto, Y. Suzuki, N. Shimozawa, H. Takano, O. Onodera, M. Nishizawa, P. Aubourg, and S. Tsuji Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes Neurogenetics 12 2011 41 50
48. J.M. Powers, D.P. DeCiero, M. Ito, A.B. Moser, and H.W. Moser Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy J. Neuropathol. Exp. Neurol. 59 2000 89 102
49. J.M. Powers, D.P. DeCiero, C. Cox, E.K. Richfield, M. Ito, A.B. Moser, and H.W. Moser The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria J. Neuropathol. Exp. Neurol. 60 2001 493 501
50. H.W. Moser, A.B. Moser, K.D. Smith, A. Bergin, J. Borel, J. Shankroff, O.C. Stine, C. Merette, J. Ott, and W. Krivit et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy J. Inherit. Metab. Dis. 15 1992 645 664
51. J.M. Powers Adreno-leukodystrophy: a personal historical note Acta Neuropathol. 109 2005 124 127
52. J. Lopez-Erauskin, J. Galino, M. Ruiz, J.M. Cuezva, I. Fabregat, D. Cacabelos, J. Boada, J. Martinez, I. Ferrer, R. Pamplona, F. Villarroya, M. Portero-Otin, S. Fourcade, and A. Pujol Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy Hum. Mol. Genet. 22 2013 3296 3305
53. S. Fourcade, J. Lopez-Erauskin, J. Galino, C. Duval, A. Naudi, M. Jove, S. Kemp, F. Villarroya, I. Ferrer, R. Pamplona, M. Portero-Otin, and A. Pujol Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy Hum. Mol. Genet. 17 2008 1762 1773
54. J. Lopez-Erauskin, S. Fourcade, J. Galino, M. Ruiz, A. Schluter, A. Naudi, M. Jove, M. Portero-Otin, R. Pamplona, I. Ferrer, and A. Pujol Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy Ann. Neurol. 70 2011 84 92
55. E. Galea, N. Launay, M. Portero-Otin, M. Ruiz, R. Pamplona, P. Aubourg, I. Ferrer, and A. Pujol Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim. Biophys. Acta 1822 2012 1475 1488
56. C.R. Vargas, M. Wajner, L.R. Sirtori, L. Goulart, M. Chiochetta, D. Coelho, A. Latini, S. Llesuy, A. Bello-Klein, R. Giugliani, M. Deon, and C.F. Mello Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy Biochim. Biophys. Acta 1688 2004 26 32
57. S. Petrillo, F. Piemonte, A. Pastore, G. Tozzi, C. Aiello, A. Pujol, M. Cappa, and E. Bertini Glutathione imbalance in patients with X-linked adrenoleukodystrophy Mol. Genet. Metab. 109 2013 366 370
58. S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture Hum. Mol. Genet. 17 2008 1750 1761
59. A. Bottelbergs, S. Verheijden, L. Hulshagen, D.H. Gutmann, S. Goebbels, K.A. Nave, C. Kassmann, and M. Baes Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes Glia 58 2010 1532 1543
60. C.M. Kassmann, C. Lappe-Siefke, M. Baes, B. Brugger, A. Mildner, H.B. Werner, O. Natt, T. Michaelis, M. Prinz, J. Frahm, and K.A. Nave Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes Nat. Genet. 39 2007 969 976
61. C.M. Kassmann, and K.A. Nave Oligodendroglial impact on axonal function and survival - a hypothesis Curr. Opin. Neurol. 21 2008 235 241
62. C.M. Kassmann, S. Quintes, J. Rietdorf, W. Mobius, M.W. Sereda, T. Nientiedt, G. Saher, M. Baes, and K.A. Nave A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity FEBS Lett. 585 2011 2205 2211
63. A. Fatemi, S.A. Smith, P. Dubey, K.M. Zackowski, A.J. Bastian, P.C. van Zijl, H.W. Moser, G.V. Raymond, and X. Golay Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy Neurology 64 2005 1739 1745
64. J.K. Ho, H. Moser, Y. Kishimoto, and J.A. Hamilton Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy J. Clin. Invest. 96 1995 1455 1463
65. M. Asheuer, I. Bieche, I. Laurendeau, A. Moser, B. Hainque, M. Vidaud, and P. Aubourg Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy Hum. Mol. Genet. 14 2005 1293 1303
66. J. Jang, H.C. Kang, H.S. Kim, J.Y. Kim, Y.J. Huh, D.S. Kim, J.E. Yoo, J.A. Lee, B. Lim, J. Lee, T.M. Yoon, I.H. Park, D.Y. Hwang, G.Q. Daley, and D.W. Kim Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients Ann. Neurol. 70 2011 402 409
67. H.H. Schaumburg, J.M. Powers, C.S. Raine, K. Suzuki, and E.P. Richardson Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases Arch. Neurol. 32 1975 577 591
68. J.M. Powers, Y. Liu, A.B. Moser, and H.W. Moser The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications J. Neuropathol. Exp. Neurol. 51 1992 630 643
69. N.E. Maestri, and T.H. Beaty Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy Am. J. Med. Genet. 44 1992 576 582
70. K.D. Smith, G. Sack, T. Beaty, A. Bergin, S. Naidu, A. Moser, and H. Moser A genetic-basis for the multiple phenotypes of X-linked adrenoleukodystrophy Am. J. Hum. Genet. 49 1991 165-165
71. R. Ofman, I.M. Dijkstra, C.W. van Roermund, N. Burger, M. Turkenburg, A. van Cruchten, C.E. van Engen, R.J. Wanders, and S. Kemp The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy EMBO Mol. Med. 2 2010 90 97
72. S. Kemp, and R. Wanders Biochemical aspects of X-linked adrenoleukodystrophy Brain Pathol. 20 2010 831 837
73. G.C. Korenke, P.J. Pouwels, J. Frahm, D.H. Hunneman, S. Stoeckler, E. Krasemann, W. Jost, and F. Hanefeld Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients Pediatr. Neurol. 15 1996 103 107
74. P.L. Musolino, O. Rapalino, P. Caruso, V.S. Caviness, and F.S. Eichler Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy Brain 135 2012 2676 2683
75. T.J. Putnam, and H.B. Wilcox A reducing substance found in chromophilic adenomas and in the normal anterior pituitary Am. J. Pathol. 9 1933 649 650
76. A.C. Arnold, J.S. Pepose, R.S. Hepler, and R.Y. Foos Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics Ophthalmology 91 1984 255 262
77. S. Lightman, W.I. McDonald, A.C. Bird, D.A. Francis, A. Hoskins, J.R. Batchelor, and A.M. Halliday Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis Brain 110 1987 405 414
78. T.C. Lund, P.S. Stadem, A. Panoskaltsis-Mortari, G. Raymond, W.P. Miller, J. Tolar, and P.J. Orchard Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity PLoS One 7 2012 e32218
79. M. Ito, B.M. Blumberg, D.J. Mock, A.D. Goodman, A.B. Moser, H.W. Moser, K.D. Smith, and J.M. Powers Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation J. Neuropathol. Exp. Neurol. 60 2001 1004 1019
80. G. Locatelli, S. Wortge, T. Buch, B. Ingold, F. Frommer, B. Sobottka, M. Kruger, K. Karram, C. Buhlmann, I. Bechmann, F.L. Heppner, A. Waisman, and B. Becher Primary oligodendrocyte death does not elicit anti-CNS immunity Nat. Neurosci. 15 2012 543 550
81. R. Kannagi, E. Nudelman, and S. Hakomori Possible role of ceramide in defining structure and function of membrane glycolipids Proc. Natl. Acad. Sci. U. S. A. 79 1982 3470 3474
82. Y. Tagawa, W. Laroy, L. Nimrichter, S.E. Fromholt, A.B. Moser, H.W. Moser, and R.L. Schnaar Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids Neurochem. Res. 27 2002 847 855
83. G.V. Raymond, R. Seidman, T.S. Monteith, E. Kolodny, S. Sathe, A. Mahmood, and J.M. Powers Head trauma can initiate the onset of adreno-leukodystrophy J. Neurol. Sci. 290 2010 70 74
84. M. Weller, W. Liedtke, D. Petersen, H. Opitz, and M. Poremba Very-late-onset adrenoleukodystrophy: possible precipitation of demyelination by cerebral contusion Neurology 42 1992 367 370
85. J. Berger, A. Pujol, P. Aubourg, and S. Forss-Petter Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy Brain Pathol. 20 2010 845 856
86. I. Ferrer, P. Aubourg, and A. Pujol General aspects and neuropathology of X-linked adrenoleukodystrophy Brain Pathol. 20 2010 817 830
87. J.M. Powers, Z. Pei, A.K. Heinzer, R. Deering, A.B. Moser, H.W. Moser, P.A. Watkins, and K.D. Smith Adreno-leukodystrophy: oxidative stress of mice and men J. Neuropathol. Exp. Neurol. 64 2005 1067 1079
88. N.H. Varvel, S.A. Grathwohl, F. Baumann, C. Liebig, A. Bosch, B. Brawek, D.R. Thal, I.F. Charo, F.L. Heppner, A. Aguzzi, O. Garaschuk, R.M. Ransohoff, and M. Jucker Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells Proc. Natl. Acad. Sci. U. S. A. 109 2012 18150 18155
89. N. Davoust, C. Vuaillat, G. Androdias, and S. Nataf From bone marrow to microglia: barriers and avenues Trends Immunol. 29 2008 227 234
90. J.M. Powers, H.W. Moser, A.B. Moser, and H.H. Schaumburg Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis Hum. Pathol. 13 1982 1013 1019
91. A. Petryk, L.E. Polgreen, S. Chahla, W. Miller, and P.J. Orchard No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy Bone Marrow Transplant. 47 2012 1377 1378
92. J.M. Powers, and H.H. Schaumburg The testis in adreno-leukodystrophy Am. J. Pathol. 102 1981 90 98
93. W. Brennemann, W. Kohler, S. Zierz, and D. Klingmuller Testicular dysfunction in adrenomyeloneuropathy Eur. J. Endocrinol. 137 1997 34 39
94. J.N. Harris-Jones, and P.G. Nixon Familial Addison's disease with spastic paraplegia J. Clin. Endocrinol. Metab. 15 1955 739 744